<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38817886</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2398-8835</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Health science reports</Title><ISOAbbreviation>Health Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Beyond polio: Exploring non-polio enteroviruses, global health preparedness, and the "Disease X" paradigm.</ArticleTitle><Pagination><StartPage>e2147</StartPage><MedlinePgn>e2147</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2147</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/hsr2.2147</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="UNASSIGNED">Disease X represents the possibility that an unidentified infection may spread globally and start a pandemic. This study explored various aspects of emerging non-polio enteroviruses (NPEVs) as a possible source of "Disease X," an enigmatic agent declared by the World Health Organization, and discussed the potential impact of NPEVs on global public health.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this perspective article, we collected information from publicly available sources such as Google Scholar, PubMed, and Scopus. We used NPEVs, viral diseases, pandemics, and zoonotic diseases as keywords. We extracted information from the most relevant articles.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Notable outbreaks caused by NPEVs include enterovirus D68 (EV-D68) and enterovirus A71 (EV-A71), among many others. With a focus on therapeutic and preventative components, alternate modes of therapy, and the development of broad-spectrum antivirals, this analysis looks at the origin, epidemiology, genetic alterations, transmission dynamics, and disease pathophysiology of NPEVs. The information presented in the review indicates the current risk assessment of NPEVs, taking into account the following factors: the need for research and therapeutic interventions, the diversity of clinical manifestations, the impact of genetic variability on virulence, the persistence of emergence despite vaccination efforts, recurrent outbreaks, and the global impact of these viruses.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">There is a possibility that NPEVs could trigger global pandemics based on their zoonotic origins and urges for complete readiness, continuous research, cooperation, and a comprehensive strategy to combat emerging infectious diseases in a constantly changing global environment. It is peak time to acknowledge how important it is to abide by safety and health laws to prevent these illnesses.</AbstractText><CopyrightInformation>© 2024 The Author(s). Health Science Reports published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anjum</LastName><ForeName>Ramisa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pharmacy University of Asia Pacific Dhaka Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haque</LastName><ForeName>Md Aminul</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>School of Pharmacy BRAC University Dhaka Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akter</LastName><ForeName>Raushanara</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Pharmacy BRAC University Dhaka Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Islam</LastName><ForeName>Md Rabiul</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0003-2820-3144</Identifier><AffiliationInfo><Affiliation>School of Pharmacy BRAC University Dhaka Bangladesh.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Health Sci Rep</MedlineTA><NlmUniqueID>101728855</NlmUniqueID><ISSNLinking>2398-8835</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">disease X</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">non‐polio enterovirus</Keyword><Keyword MajorTopicYN="N">pandemics</Keyword><Keyword MajorTopicYN="N">viral diseases</Keyword><Keyword MajorTopicYN="N">zoonotic disease</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>31</Day><Hour>3</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38817886</ArticleId><ArticleId IdType="pmc">PMC11136642</ArticleId><ArticleId IdType="doi">10.1002/hsr2.2147</ArticleId><ArticleId IdType="pii">HSR22147</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Health Organization
. Prioritizing diseases for research and development in emergency contexts. WHO. 2023. Accessed November 29, 2023. https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-contexts
</Citation></Reference><Reference><Citation>Jiang S, Shi ZL. The first disease X is caused by a highly transmissible acute respiratory syndrome coronavirus. Virologica Sinica. 2020;35(3):263‐265. 10.1007/s12250-020-00206-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00206-5</ArticleId><ArticleId IdType="pmc">PMC7091198</ArticleId><ArticleId IdType="pubmed">32060789</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM. The life cycle of non‐polio enteroviruses and how to target it. Nat Rev Microbiol. 2018;16(6):368‐381. 10.1038/s41579-018-00054</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-00054</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J, Huang M, Li J, et al. Enterovirus D68 VP3 targets the interferon regulatory factor 7 to inhibit type i interferon response. Microbiol Spectrum. 2023;11(3):e0413822. 10.1128/spectrum.04138-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.04138-22</ArticleId><ArticleId IdType="pmc">PMC10269600</ArticleId><ArticleId IdType="pubmed">37125923</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Wang M, Li D, et al. The impact of the COVID‐19 pandemic on the number of hand, foot, and mouth disease due to enterovirus 71 infections. J Infect. 2023;86(4):e111‐e113. 10.1016/j.jinf.2023.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2023.02.005</ArticleId><ArticleId IdType="pmc">PMC9908569</ArticleId><ArticleId IdType="pubmed">36764394</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization
. WHO to identify pathogens that could cause future outbreaks and pandemics. WHO. 2022. Accessed November 21, 2022. https://www.who.int/news/item/21-11-2022-who-to-identify-pathogens-that-could-cause-future-outbreaks-and-pandemics
</Citation></Reference><Reference><Citation>Anasir MI, Zarif F, Poh CL. Antivirals blocking entry of enteroviruses and therapeutic potential. J Biomed Sci. J2021;28(1):10. 10.1186/s12929-021-00708-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-021-00708-8</ArticleId><ArticleId IdType="pmc">PMC7811253</ArticleId><ArticleId IdType="pubmed">33451326</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu ST, Kobayashi K, Bi X, et al. Newly emerged enterovirus‐A71 C4 sublineage may be more virulent than B5 in the 2015‐2016 hand‐foot‐and‐mouth disease outbreak in northern Vietnam. Sci Rep. 2020;10(1):159. 10.1038/s41598-019-56703-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-56703-5</ArticleId><ArticleId IdType="pmc">PMC6957505</ArticleId><ArticleId IdType="pubmed">31932599</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffett DB, Llewellyn A, Singh H, et al. Progress toward poliovirus containment implementation: worldwide, 2019‐2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1330‐1333. 10.15585/mmwr.mm6937a7</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6937a7</ArticleId><ArticleId IdType="pmc">PMC7498175</ArticleId><ArticleId IdType="pubmed">32941411</ArticleId></ArticleIdList></Reference><Reference><Citation>Uprety P, Graf EH. Enterovirus infection and acute flaccid myelitis. Current Op Virol. 2020;40:55‐60. 10.1016/j.coviro.2020.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2020.06.006</ArticleId><ArticleId IdType="pubmed">32711392</ArticleId></ArticleIdList></Reference><Reference><Citation>Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia‐Pacific region. J Biomed Sci. 2019;26(1):75. 10.1186/s12929-019-0573-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0573-2</ArticleId><ArticleId IdType="pmc">PMC6798416</ArticleId><ArticleId IdType="pubmed">31627753</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm‐Hansen CC, Midgley SE, Fischer TK. Global emergence of enterovirus D68: a systematic review. Lancet Infect Dis. 2016;16(5):e64‐e75. 10.1016/S1473-3099(15)00543-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00543-5</ArticleId><ArticleId IdType="pubmed">26929196</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrés C, Vila J, Creus‐Costa A, et al. Enterovirus D68 in hospitalized children, Barcelona, Spain, 2014‐2021. Emerging Infect Dis. 2022;28(7):1327‐1331. 10.3201/eid2807.220264</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2807.220264</ArticleId><ArticleId IdType="pmc">PMC9239859</ArticleId><ArticleId IdType="pubmed">35731133</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah MM, Perez A, Lively JY, et al. Enterovirus D68‐associated acute respiratory illness: new vaccine surveillance network, United States, July–November 2018–2020. MMWR Morb Mortal Wkly Rep. 2021;70(47):1623‐1628. 10.15585/mmwr.mm7047a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7047a1</ArticleId><ArticleId IdType="pmc">PMC8612514</ArticleId><ArticleId IdType="pubmed">34818320</ArticleId></ArticleIdList></Reference><Reference><Citation>Fall A, Gallagher N, Morris CP, et al. Circulation of enterovirus D68 during period of increased influenza‐like illness, maryland, USA, 2021. Emerging Infect Dis. 2022;28(7):1525‐1527. 10.3201/eid2807.212603</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2807.212603</ArticleId><ArticleId IdType="pmc">PMC9239864</ArticleId><ArticleId IdType="pubmed">35642471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma KC, Winn A, Moline HL, et al. Increase in acute respiratory illnesses among children and adolescents associated with rhinoviruses and enteroviruses, including enterovirus D68: United States, July‐September 2022. MMWR Morb Mortal Wkly Rep. 2022;71(40):1265‐1270. 10.15585/mmwr.mm7140e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7140e1</ArticleId><ArticleId IdType="pmc">PMC9541033</ArticleId><ArticleId IdType="pubmed">36201400</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop KS, Albert J, Anton A, et al. Re‐emergence of enterovirus D68 in Europe after easing the COVID‐19 lockdown, September 2021. Euro Surveill. 2021;26(45):2100998. 10.2807/1560-7917.ES.2021.26.45.2100998</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.45.2100998</ArticleId><ArticleId IdType="pmc">PMC8646978</ArticleId><ArticleId IdType="pubmed">34763750</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley CM, Watson JT, Nix WA, et al. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation. Lancet Resp Med. 2015;3(11):879‐887. 10.1016/S2213-2600(15)00335-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(15)00335-5</ArticleId><ArticleId IdType="pmc">PMC5693332</ArticleId><ArticleId IdType="pubmed">26482320</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidd S, Lopez AS, Konopka‐Anstadt JL, Nix WA, Routh JA, Oberste MS. Enterovirus D68‐associated acute flaccid myelitis, United States, 2020. Emerging Infect Dis. 2020;26(10):e201630. 10.3201/eid2610.201630</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2610.201630</ArticleId><ArticleId IdType="pmc">PMC7510737</ArticleId><ArticleId IdType="pubmed">32833616</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P, Faase JAJ, Toyoda H, Paul A, Wimmer E, Gorbalenya AE. Evidence for emergence of diverse polioviruses from C‐cluster coxsackie A viruses and implications for global poliovirus eradication. Proc Natl Acad Sci. 2007;104:9457‐9462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1874223</ArticleId><ArticleId IdType="pubmed">17517601</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandary M, Poh C. Changes in the EV‐A71 genome through recombination and spontaneous mutations: impact on virulence. Viruses. 2018;10(6):320. 10.3390/v10060320</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10060320</ArticleId><ArticleId IdType="pmc">PMC6024729</ArticleId><ArticleId IdType="pubmed">29895721</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons‐Salort M, Parker EPK, Grassly NC. The epidemiology of non‐polio enteroviruses: recent advances and outstanding questions. Curr Opin Infect Dis. 2015;28(5):479‐487. 10.1097/QCO.0000000000000187</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000187</ArticleId><ArticleId IdType="pmc">PMC6624138</ArticleId><ArticleId IdType="pubmed">26203854</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolhouse ME, Howey R, Gaunt E, Reilly L, Chase‐Topping M, Savill N. Temporal trends in the discovery of human viruses. Proc Biol Sci. 2008;275(1647):2111‐2115. 10.1098/rspb.2008.0294</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2008.0294</ArticleId><ArticleId IdType="pmc">PMC2475551</ArticleId><ArticleId IdType="pubmed">18505720</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. Polio enterovirus‐transmission. 2020. https://www.cdc.gov/non-polio-enterovirus/about/transmission.html
</Citation></Reference><Reference><Citation>Miwatashi W, Ishida M, Takashino A, et al. Mouse Scarb2 modulates EV‐A71 pathogenicity in neonatal mice. J Virol. 2022;96(15):e0056122. 10.1128/jvi.00561-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00561-22</ArticleId><ArticleId IdType="pmc">PMC9364792</ArticleId><ArticleId IdType="pubmed">35867561</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. Enterovirus D68. 2023. Accessed December 23, 2023. https://www.cdc.gov/non-polio-enterovirus/about/ev-d68.html#future
</Citation></Reference><Reference><Citation>Suresh S, Forgie S, Robinson J. Non‐polio enterovirus detection with acute flaccid paralysis: a systematic review. J Med Virol. 2018;90(1):3‐7. 10.1002/jmv.24933</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24933</ArticleId><ArticleId IdType="pubmed">28857219</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. Non‐polio Enterovirus: Symptoms. 2020. Accessed November 29, 2023. Non‐polio enterovirus: symptoms Non‐polio enterovirus: symptoms. https://www.cdc.gov/non-polio-enterovirus/about/symptoms.html
</Citation></Reference><Reference><Citation>Frost J, Rudy MJ, Leser JS, et al. Telaprevir treatment reduces paralysis in a mouse model of enterovirus D68 acute flaccid myelitis. J Virol. 2023;97(5):e0015623. 10.1128/jvi.00156-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00156-23</ArticleId><ArticleId IdType="pmc">PMC10231134</ArticleId><ArticleId IdType="pubmed">37154751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma E, Chan KC, Cheng P, Wong C, Chuang SK. The enterovirus 71 epidemic in 2008: public health implications for Hong Kong. Int J Infect Dis. 2010;14(9):e775‐e780. 10.1016/j.ijid.2010.02.2265</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.02.2265</ArticleId><ArticleId IdType="pubmed">20599410</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein M, Chong P. Is a multivalent hand, foot, and mouth disease vaccine feasible? Hum Vaccines Immunother. 2015;11(11):2688‐2704. 10.1080/21645515.2015.1049780</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2015.1049780</ArticleId><ArticleId IdType="pmc">PMC4685682</ArticleId><ArticleId IdType="pubmed">26009802</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenista JA, Powell KR, Menegus MA. Epidemiology of neonatal enterovirus infection. J Pediatr. 1984;104(5):685‐690. 10.1016/s0022-3476(84)80944-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(84)80944-0</ArticleId><ArticleId IdType="pubmed">6325656</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrés C, Vila J, Creus‐Costa A, et al. Enterovirus D68 in hospitalized children, Barcelona, Spain, 2014‐2021. Emerging Infect Dis. 2022;28(7):1327‐1331. 10.3201/eid2807.220264</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2807.220264</ArticleId><ArticleId IdType="pmc">PMC9239859</ArticleId><ArticleId IdType="pubmed">35731133</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Musharrafieh R, Zheng M, Wang J. Enterovirus D68 antivirals: past, present, and future. ACS Infect Dis. 2020;6(7):1572‐1586. 10.1021/acsinfecdis.0c00120</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00120</ArticleId><ArticleId IdType="pmc">PMC8055446</ArticleId><ArticleId IdType="pubmed">32352280</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Hu Y, Zheng M. Enterovirus A71 antivirals: past, present, and future. Acta Pharm Sin B. 2022;12(4):1542‐1566. 10.1016/j.apsb.2021.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2021.08.017</ArticleId><ArticleId IdType="pmc">PMC9279511</ArticleId><ArticleId IdType="pubmed">35847514</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization
. Enterovirus 71. 2023. Accessed December 22, 2023. https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/enterovirus-71
</Citation></Reference><Reference><Citation>Murphy OC, Messacar K, Benson L, et al. Acute flaccid myelitis: cause, diagnosis, and management. Lancet. 2021;397(10271):334‐346. 10.1016/S0140-6736(20)32723-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32723-9</ArticleId><ArticleId IdType="pmc">PMC7909727</ArticleId><ArticleId IdType="pubmed">33357469</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YL, Chen CM, Wang ET, et al. The secular trend of enterovirus A71 after the implementation of preventive measures in Taiwan. BMC Public Health. 2022;22(1):1483. 10.1186/s12889-022-13916-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-13916-0</ArticleId><ArticleId IdType="pmc">PMC9351194</ArticleId><ArticleId IdType="pubmed">35927656</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W, Mar KB, Sari L, et al. TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity. Cell. 2021;184(13):3410‐3425 e17. 10.1016/j.cell.2021.04.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.047</ArticleId><ArticleId IdType="pmc">PMC8276836</ArticleId><ArticleId IdType="pubmed">34062120</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassetti MC, Pierson TC, Patterson LJ, et al. Prototype pathogen approach for vaccine and monoclonal antibody development: a critical component of the NIAID plan for pandemic preparedness. J Infect Dis. 2023;227(12):1433‐1441. 10.1093/infdis/jiac296</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac296</ArticleId><ArticleId IdType="pmc">PMC9384504</ArticleId><ArticleId IdType="pubmed">35876700</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann G, Kawaoka Y. Which virus will cause the next pandemic? Viruses. 2023;15(1):199. 10.3390/v15010199</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010199</ArticleId><ArticleId IdType="pmc">PMC9864092</ArticleId><ArticleId IdType="pubmed">36680238</ArticleId></ArticleIdList></Reference><Reference><Citation>Noisumdaeng P, Puthavathana P. Molecular evolutionary dynamics of enterovirus A71, coxsackievirus A16 and coxsackievirus A6 causing hand, foot and mouth disease in Thailand, 2000‐2022. Sci Rep. 2023;13(1):17359. 10.1038/s41598-023-44644-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-44644-z</ArticleId><ArticleId IdType="pmc">PMC10576028</ArticleId><ArticleId IdType="pubmed">37833525</ArticleId></ArticleIdList></Reference><Reference><Citation>Salyer SJ, Silver R, Simone K, Barton Behravesh C. Prioritizing zoonoses for global health capacity building‐themes from one health zoonotic disease workshops in 7 countries, 2014‐2016. Emerging Infect Dis. 2017;23(13):S55‐S64. 10.3201/eid2313.170418</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2313.170418</ArticleId><ArticleId IdType="pmc">PMC5711306</ArticleId><ArticleId IdType="pubmed">29155664</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly TR, Karesh WB, Johnson CK, et al. One health proof of concept: bringing a transdisciplinary approach to surveillance for zoonotic viruses at the human‐wild animal interface. Prev Vet Med. 2017;137(Pt B):112‐118. 10.1016/j.prevetmed.2016.11.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prevetmed.2016.11.023</ArticleId><ArticleId IdType="pmc">PMC7132382</ArticleId><ArticleId IdType="pubmed">28034593</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwind JS, Goldstein T, Thomas K, Mazet JA, Smith WA. Capacity building efforts and perceptions for wildlife surveillance to detect zoonotic pathogens: comparing stakeholder perspectives. BMC Public Health. 2014;14:684. 10.1186/1471-2458-14-684</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-14-684</ArticleId><ArticleId IdType="pmc">PMC4096412</ArticleId><ArticleId IdType="pubmed">24996851</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Broberg E, Benschop K, et al. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. J Clin Virol 2018;101:11‐17. 10.1016/j.jcv.2018.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.01.008</ArticleId><ArticleId IdType="pubmed">29414181</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>